Total Payments
$110,269
2024 Payments
$3,975
Companies
51
Transactions
888
Medicare Patients
3,588
Medicare Billing
$530,988
Payment Breakdown by Category
Other$65,050 (59.0%)
Food & Beverage$24,786 (22.5%)
Travel$14,613 (13.3%)
Consulting$5,500 (5.0%)
Education$320.51 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $65,050 | 24 | 59.0% |
| Food and Beverage | $24,786 | 773 | 22.5% |
| Travel and Lodging | $14,613 | 48 | 13.3% |
| Consulting Fee | $5,500 | 1 | 5.0% |
| Education | $320.51 | 42 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $74,179 | 187 | $0 (2023) |
| Boston Scientific Corporation | $9,045 | 74 | $0 (2024) |
| Bard Peripheral Vascular, Inc. | $6,313 | 18 | $0 (2024) |
| Medtronic, Inc. | $4,150 | 49 | $0 (2024) |
| Medtronic Vascular, Inc. | $2,993 | 61 | $0 (2020) |
| Abbott Laboratories | $2,066 | 46 | $0 (2024) |
| Cardiovascular Systems Inc. | $1,893 | 9 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $1,321 | 57 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $941.38 | 57 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $900.27 | 32 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,975 | 90 | Boston Scientific Corporation ($1,598) |
| 2023 | $5,039 | 107 | Medtronic, Inc. ($3,061) |
| 2022 | $7,915 | 100 | Bard Peripheral Vascular, Inc. ($5,890) |
| 2021 | $2,354 | 113 | Medtronic, Inc. ($399.26) |
| 2020 | $13,695 | 122 | Amarin Pharma Inc. ($11,703) |
| 2019 | $66,776 | 175 | Amarin Pharma Inc. ($61,650) |
| 2018 | $4,403 | 87 | Cardiovascular Systems Inc. ($1,751) |
| 2017 | $6,112 | 94 | BOSTON SCIENTIFIC CORPORATION ($2,959) |
All Payment Transactions
888 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/17/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $148.52 | General |
| Category: EndoVenous Therapies | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2024 | AGEPHA Pharma FZ LLC | LODOCO (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Cardiovascular Diseases | ||||||
| 12/04/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Heart Failure | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $1.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $25.37 | General |
| Category: Cardiovascular | ||||||
| 11/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: DIABETES | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Cardiology | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/12/2024 | ASAHI INTECC USA, INC. | PERIPHERAL VASCULAR (Device) | Food and Beverage | Cash or cash equivalent | $90.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/04/2024 | Boston Scientific Corporation | RESONATE EL ICD VR (Device) | Food and Beverage | In-kind items and services | $121.08 | General |
| Category: RESONATE_CRM | ||||||
| 10/02/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.76 | General |
| 09/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.70 | General |
| Category: Cardiovascular | ||||||
| 09/17/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $140.00 | General |
| Category: Transcatheter Valve Systems | ||||||
| 09/16/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: Heart Failure | ||||||
| 09/12/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.14 | General |
| 09/11/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/10/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: Heart Failure | ||||||
| 08/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Obesity | ||||||
| 08/29/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.03 | General |
| 08/22/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.72 | General |
| Category: Cardiovascular | ||||||
| 08/21/2024 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 852 | 1,498 | $702,616 | $183,551 |
| 2022 | 14 | 790 | 1,386 | $615,044 | $120,913 |
| 2021 | 18 | 1,042 | 1,613 | $603,182 | $126,050 |
| 2020 | 18 | 904 | 1,417 | $491,886 | $100,474 |
Total Patients
3,588
Total Services
5,914
Medicare Billing
$530,988
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 28 | 28 | $98,000 | $54,202 | 55.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 162 | 399 | $150,300 | $35,524 | 23.6% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 28 | 28 | $23,240 | $18,220 | 78.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 122 | 124 | $153,200 | $16,980 | 11.1% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 24 | 24 | $67,560 | $16,242 | 24.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 25 | 25 | $35,875 | $8,504 | 23.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 44 | 176 | $45,010 | $6,795 | 15.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $22,035 | $4,993 | 22.7% |
| 78434 | Nuclear medicine study of heart muscle blood flow by pet | Office | 2023 | 27 | 27 | $5,400 | $3,932 | 72.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 163 | 367 | $19,190 | $3,815 | 19.9% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 22 | 23 | $14,260 | $3,519 | 24.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 64 | 66 | $23,100 | $3,381 | 14.6% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 25 | 26 | $4,081 | $2,454 | 60.1% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 11 | 77 | $19,250 | $2,293 | 11.9% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 25 | 25 | $6,185 | $1,225 | 19.8% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 18 | 19 | $14,250 | $1,040 | 7.3% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 21 | 21 | $1,680 | $430.08 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 172 | 412 | $153,850 | $37,681 | 24.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 113 | 123 | $150,825 | $18,502 | 12.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 47 | 48 | $72,530 | $18,011 | 24.8% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2022 | 21 | 23 | $64,745 | $16,911 | 26.1% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2022 | 28 | 32 | $19,840 | $4,546 | 22.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 22 | 92 | $43,200 | $4,461 | 10.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 41 | 41 | $20,850 | $4,376 | 21.0% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2022 | 37 | 39 | $6,024 | $3,925 | 65.1% |
About Dr. Andres Mesa, M.D
Dr. Andres Mesa, M.D is a Cardiovascular Disease healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891721338.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andres Mesa, M.D has received a total of $110,269 in payments from pharmaceutical and medical device companies, with $3,975 received in 2024. These payments were reported across 888 transactions from 51 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($65,050).
As a Medicare-enrolled provider, Mesa has provided services to 3,588 Medicare beneficiaries, totaling 5,914 services with total Medicare billing of $530,988. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Houston, TX
- Active Since 06/25/2006
- Last Updated 04/24/2019
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1891721338
Products in Payments
- Vascepa (Drug) $74,179
- WATCHMAN (Device) $2,420
- VenaSeal (Device) $1,717
- EMBLEM (Device) $1,408
- Coronary Orbital Atherectomy System (Device) $1,296
- GENERAL - THERAPIES (Device) $1,236
- ENTRESTO (Drug) $1,110
- XARELTO (Drug) $941.38
- ELIQUIS (Drug) $847.27
- FARXIGA (Drug) $768.91
- COREVALVE EVOLUT R (Device) $679.71
- CoreValve Evolut (Device) $604.35
- Venclose Maven Catheter (Device) $575.93
- Xience V coronary stent system (Device) $563.88
- ClosureFast (Device) $525.17
- RESONATE (Device) $516.40
- Peripheral Orbital Atherectomy System (Device) $454.84
- VERQUVO (Drug) $434.50
- LifeVest (Device) $420.80
- JARDIANCE (Drug) $413.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Houston
Reynolds Delgado, M.d, M.D
Cardiovascular Disease — Payments: $600,466
Cardiovascular Disease $600,466
Dr. Miguel Valderrabano, Md, MD
Cardiovascular Disease — Payments: $471,736
Cardiovascular Disease $471,736
Asif Ali, Md, MD
Cardiovascular Disease — Payments: $461,190
Cardiovascular Disease $461,190
Mr. Mehdi Razavi, Md, MD
Cardiovascular Disease — Payments: $433,792
Cardiovascular Disease $433,792
Dr. Michele Sartori, M.d, M.D
Cardiovascular Disease — Payments: $278,682
Cardiovascular Disease $278,682
Barry Trachtenberg, Md, MD
Cardiovascular Disease — Payments: $273,547
Cardiovascular Disease $273,547